Clinical Trial Update: IOP Lowering Efficacy of Travoprost/Brinzolamide Fixed Combination Ophthalmic Suspension in Patients With Open-Angle Glaucoma or Ocular Hypertension [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating the intraocular pressure-lowering efficacy of a fixed-dose travoprost/brinzolamide ophthalmic suspension in open-angle glaucoma or ocul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ocular Hypertension
• Open-angle Glaucoma

Drugs mentioned

• Travoprost/brinzolamide fixed-dose combination ophthalmic suspension (travoprost/brinzolamide fixed-dose combination)

Snippet

Sponsor: Alcon Research | Conditions: Open-angle Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED